Suppression of PTEN expression during aggregation with retinoic acid in P19 mouse embryonal carcinoma cells

Biochemical and Biophysical Research Communications

Volumn 347, Issue 3, 2006, Pages 715-722

  Lee, Joon Ho ^a   Shin, Soon Young ^a   Kim, Sungyong ^a   Choo, Jaebum ^a   Lee, Young Han ^a  

^a Hanyang University   (South Korea)

Author keywords

Neuronal differentiation; P19 embryonal carcinoma; PTEN; Trans retinoic acid

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATASE AND TENSIN HOMOLOG DELETED ON CHROMOSOME 10 PROTEIN; PROTEIN; PROTEIN KINASE B; PROTEIN SERINE KINASE; RETINOIC ACID; THREONINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL AGGREGATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYONAL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; CARCINOMA, EMBRYONAL; CELL DIFFERENTIATION; CELL SHAPE; DOWN-REGULATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; TRANSCRIPTION, GENETIC; TRETINOIN;

EID: 33746190657     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.06.161     Document Type: Article

References (48)

1. McBurney M.W., Jones-Villeneuve E.M., Edwards M.K., and Anderson P.J. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 299 (1982) 165-167
2. Rossant J., and McBurney M.W. The developmental potential of a euploid male teratocarcinoma cell line after blastocyst injection. J. Embryol. Exp. Morphol. 70 (1982) 99-112
3. Jones-Villeneuve E.M., Rudnicki M.A., Harris J.F., and McBurney M.W. Retinoic acid-induced neural differentiation of embryonal carcinoma cells. Mol. Cell. Biol. 3 (1983) 2271-2279
4. Aizawa T., Haga S., and Yoshikawa K. Neural differentiation-associated generation of microglia-like phagocytes in murine embryonal carcinoma cell line. Brain Res. Dev. Brain Res. 59 (1991) 89-97
5. Martin G.R., and Evans M.J. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc. Natl. Acad. Sci. USA 72 (1975) 1441-1445
6. Skerjanc I.S., Slack R.S., and McBurney M.W. Cellular aggregation enhances MyoD-directed skeletal myogenesis in embryonal carcinoma cells. Mol. Cell. Biol. 14 (1994) 8451-8459
7. Vidricaire G., Jardine K., and McBurney M.W. Expression of the Brachyury gene during mesoderm development in differentiating embryonal carcinoma cell cultures. Development 120 (1994) 115-122
8. Mendelsohn C., Lohnes D., Decimo D., Lufkin T., LeMeur M., Chambon P., and Mark M. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120 (1994) 2749-2771
9. Kastner P., Mark M., and Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?. Cell 83 (1995) 859-869
10. Jiang H., and Kochhar D.M. Induction of tissue transglutaminase and apoptosis by retinoic acid in the limb bud. Teratology 46 (1992) 333-340
11. Dupe V., Ghyselinck N.B., Thomazy V., Nagy L., Davies P.J., Chambon P., and Mark M. Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. Dev. Biol. 208 (1999) 30-43
12. Glozak M.A., and Rogers M.B. Specific induction of apoptosis in P19 embryonal carcinoma cells by retinoic acid and BMP2 or BMP4. Dev. Biol. 179 (1996) 458-470
13. Horn V., Minucci S., Ogryzko V.V., Adamson E.D., Howard B.H., Levin A.A., and Ozato K. RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells. FASEB J. 10 (1996) 1071-1077
14. Okazawa H., Shimizu J., Kamei M., Imafuku I., Hamada H., and Kanazawa I. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells. J. Cell Biol. 132 (1996) 955-968
15. Yamada T., Suzuki N., Hiraoka N., Matsuoka K., Fukushima S., Hashiguchi A., and Hata J. Apoptosis of human embryonal carcinoma cells with in vitro differentiation. Cell Struct. Funct. 21 (1996) 53-61
16. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., and Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275 (1997) 661-665
17. Crowder R.J., and Freeman R.S. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J. Neurosci. 18 (1998) 2933-2943
18. Eves E.M., Xiong W., Bellacosa A., Kennedy S.G., Tsichlis P.N., Rosner M.R., and Hay N. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol. Cell. Biol. 18 (1998) 2143-2152
19. Lopez-Carballo G., Moreno L., Masia S., Perez P., and Barettino D. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J. Biol. Chem. 277 (2002) 25297-25304
20. Andjelkovic M., Alessi D.R., Meier R., Fernandez A., Lamb N.J., Frech M., Cron P., Cohen P., Lucocq J.M., and Hemmings B.A. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272 (1997) 31515-31524
21. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., and Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
22. Brunet A., Datta S.R., and Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11 (2001) 297-305
23. Jackson T.R., Blader I.J., Hammonds-Odie L.P., Burga C.R., Cooke F., Hawkins P.T., Wolf A.G., Heldman K.A., and Theibert A.B. Initiation and maintenance of NGF-stimulated neurite outgrowth requires activation of a phosphoinositide 3-kinase. J. Cell Sci. 109 (1996) 289-300
24. Li D.M., and Sun H. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Natl. Acad. Sci. USA 95 (1998) 15406-15411
25. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K., Lin H., Ligon A.H., Langford L.A., Baumgard M.L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D.H., and Tavtigian S.V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15 (1997) 356-362
26. Cantley L.C., and Neel B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA 96 (1999) 4240-4245
27. Shin S.Y., Kim C.G., Hong D.D., Kim J.H., and Lee Y.H. Implication of Egr-1 in trifluoperazine-induced growth inhibition in human U87MG glioma cells. Exp. Mol. Med. 36 (2004) 380-386
28. Sakurada A., Hamada H., Fukushige S., Yokoyama T., Yoshinaga K., Furukawa T., Sato S., Yajima A., Sato M., Fujimura S., and Horii A. Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer. Int. J. Oncol. 15 (1999) 1069-1074
29. Shin S.Y., Bahk Y.Y., Ko J., Chung I.Y., Lee Y.S., Downward J., Eibel H., Sharma P.M., Olefsky J.M., Kim Y.H., Lee B., and Lee Y.H. Suppression of Egr-1 transcription through targeting of the serum response factor by oncogenic H-Ras. EMBO J. 25 (2006) 1093-1103
30. Kaufmann S.H., Desnoyers S., Ottaviano Y., Davidson N.E., and Poirier G.G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53 (1993) 3976-3985
31. Shah G.M., Shah R.G., and Poirier G.G. Different cleavage pattern for poly(ADP-ribose) polymerase during necrosis and apoptosis in HL-60 cells. Biochem. Biophys. Res. Commun. 229 (1996) 838-844
32. Franke T.F., Kaplan D.R., and Cantley L.C. PI3K: downstream AKTion blocks apoptosis. Cell 88 (1997) 435-437
33. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (1997) 1943-1947
34. Musatov S., Roberts J., Brooks A.I., Pena J., Betchen S., Pfaff D.W., and Kaplitt M.G. Inhibition of neuronal phenotype by PTEN in PC12 cells. Proc. Natl. Acad. Sci. USA 101 (2004) 3627-3631
35. Lachyankar M.B., Sultana N., Schonhoff C.M., Mitra P., Poluha W., Lambert S., Quesenberry P.J., Litofsky N.S., Recht L.D., Nabi R., Miller S.J., Ohta S., Neel B.G., and Ross A.H. A role for nuclear PTEN in neuronal differentiation. J. Neurosci. 20 (2000) 1404-1413
36. Edwards S.A., Darland T., Sosnowski R., Samuels M., and Adamson E.D. The transcription factor, Egr-1, is rapidly modulated in response to retinoic acid in P19 embryonal carcinoma cells. Dev. Biol. 148 (1991) 165-173
37. Caselli A., Mazzinghi B., Camici G., Manao G., and Ramponi G. Some protein tyrosine phosphatases target in part to lipid rafts and interact with caveolin-1. Biochem. Biophys. Res. Commun. 296 (2002) 692-697
38. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., and Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15 (1996) 6541-6551
39. Zhou X.P., Gimm O., Hampel H., Niemann T., Walker M.J., and Eng C. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am. J. Pathol. 157 (2000) 1123-1128
40. Eng C. PTEN: one gene, many syndromes. Hum. Mutat. 22 (2003) 183-198
41. Cheney I.W., Johnson D.E., Vaillancourt M.T., Avanzini J., Morimoto A., Demers G.W., Wills K.N., Shabram P.W., Bolen J.B., Tavtigian S.V., and Bookstein R. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res. 58 (1998) 2331-2334
42. Di Cristofano A., Pesce B., Cordon-Cardo C., and Pandolfi P.P. Pten is essential for embryonic development and tumor suppression. Nat. Genet. 19 (1998) 348-355
43. Stambolic V., Suzuki A., Louis de la Pompa J., Brothers G.M., Mirtsos C., Sasaki T., Ruland J., Penninger J.M., Siderovski D.P., and Mak T.W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95 (1998) 29-39
44. Suzuki A., de la Pompa J.L., Stambolic V., Elia A.J., Sasaki T., del Barco Barrantes I., Ho A., Wakeham A., Itie A., Khoo W., Fukumoto M., and Mak T.W. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8 (1998) 1169-1178
45. Virolle T., Adamson E.D., Baron V., Birle D., Mercola D., Mustelin T., and de Belle I. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signaling. Nat. Cell Biol. 3 (2001) 1124-1128
46. Stambolic V., MacPherson D., Sas D., Lin Y., Snow B., Jang Y., Benchimol S., and Mak T.W. Regulation of PTEN transcription by p53. Mol. Cell 8 (2001) 317-325
47. Vasudevan K.M., Gurumurthy S., and Rangnekar V.M. Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol. Cell. Biol. 24 (2004) 1007-1021
48. Sukhatme V.P., Cao X.M., Chang L.C., Tsai-Morris C.H., Stamenkovich D., Ferreira P.C., Cohen D.R., Edwards S.A., Shows T.B., and Curran T. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53 (1988) 37-43